Apolipoprotein E ε2 and functional decline in amnestic mild cognitive impairment and Alzheimer disease.
about
The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inceptionGenetic analysis of quantitative phenotypes in AD and MCI: imaging, cognition and biomarkers2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception.APOE moderates the association between lifestyle activities and cognitive performance: evidence of genetic plasticity in aging.Associations between apolipoprotein E gene polymorphisms and Alzheimer's disease risk in a large Chinese Han population.APOEε2 is associated with milder clinical and pathological Alzheimer disease.Associations between APOE polymorphisms and seven diseases with cognitive impairment including Alzheimer's disease, frontotemporal dementia, and dementia with Lewy bodies in southeast ChinaApolipoprotein E ε4 is superior to apolipoprotein E ε2 in predicting cognitive scores over 30 months.Protective effect of APOE epsilon 2 on intrinsic functional connectivity of the entorhinal cortex is associated with better episodic memory in elderly individuals with risk factors for Alzheimer's diseaseGenome research in pre-dementia stages of Alzheimer's disease.Biomarkers and Functional Decline in Prodromal Alzheimer's Disease.Functional Disability in Mild Cognitive Impairment: A Systematic Review and Meta-Analysis.Differential Effects of APOE Genotypes on the Anterior and Posterior Subnetworks of Default Mode Network in Amnestic Mild Cognitive Impairment.The Association of Apolipoprotein E Gene Polymorphism With Cognitive Performance in Nondemented Polish Adults Aged 55 to 75.Meta-Analysis of the Relationship between the Gene and the Onset of Parkinson's Disease Dementia
P2860
Q27006831-EBEA3EA4-0C1B-42B8-82AD-A49DE43EE964Q28542010-3E788299-E4EA-4CEE-9ED0-A46C10C7D865Q30971403-4BB671D2-018D-42AD-8FB9-47B9D383F25CQ33895819-083667F3-0CB7-42CF-A0CF-CDECC43A8F47Q35063476-6275DEBD-BCA9-46ED-8C02-B66451029D61Q35660968-84CAE2D3-3DC9-4CC5-94BB-5299606D20AAQ36961812-ABEABE0A-26EE-469E-AED3-E64A7C3AD5EBQ37278806-066C264A-26EF-4855-9D4C-F7222FEAC0C8Q37644772-1FCC7533-D47C-4FA0-A5D8-3DB7138CA2DDQ38847374-18DD42FB-E06E-44D4-BD36-DD31C7E6FDDFQ38858239-4D950FB6-72C2-4AEE-9EF2-5E575902C7B4Q38890671-0C91AA71-7531-4040-91EF-2FFCA2147278Q48469056-11161167-BBCA-43E2-B433-D2F27577FDD2Q50564711-4F9FB8A6-ABBF-4E17-B24B-8402784B993BQ58567981-CAC38C86-6992-47D7-97CC-9DACF24D5F72
P2860
Apolipoprotein E ε2 and functional decline in amnestic mild cognitive impairment and Alzheimer disease.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Apolipoprotein E ε2 and functi ...... airment and Alzheimer disease.
@ast
Apolipoprotein E ε2 and functi ...... airment and Alzheimer disease.
@en
type
label
Apolipoprotein E ε2 and functi ...... airment and Alzheimer disease.
@ast
Apolipoprotein E ε2 and functi ...... airment and Alzheimer disease.
@en
prefLabel
Apolipoprotein E ε2 and functi ...... airment and Alzheimer disease.
@ast
Apolipoprotein E ε2 and functi ...... airment and Alzheimer disease.
@en
P2093
P2860
P1476
Apolipoprotein E ε2 and functi ...... airment and Alzheimer disease.
@en
P2093
Aaron Bonner-Jackson
Alzheimerʼs Disease Neuroimaging Initiative
Geoffrey Tremont
Ozioma Okonkwo
P2860
P304
P356
10.1097/JGP.0B013E3182203C32
P577
2012-07-01T00:00:00Z